Perfusion is the passage of fluid through the circulatory system or lymphatic system to an organ or a tissue, usually referring to the delivery of blood to a capillary bed in tissue. Perfusion is measured as the rate at which blood is delivered to tissues or volumes of blood per unit time per unit tissue mass. Perfusion system such as heart and lungs machines delivers oxygen and removes carbon dioxide from patient’s body when heart and lungs are not performing process of oxygenation.
Asia Pacific medical perfusion technology market is presently being driven by several driving factors. China is dominating the market in Asia Pacific region. Medical perfusion technology markets demand is increasing owing to the growing cases of heart diseases such cardiovascular diseases, cerebrovascular diseases, coronary heart diseases, rheumatic heart diseases and increase in practice in organ transplantation. Also factors like increase in geriatric population, cell based research and launching new products by key players are impelling the growth of the market. However, high cost of cell based research may hamper the growth of the market.
The exclusive COVID 19 impact analysis report by Axiom MRC provides a 3600 analysis of micro and macro-economic factors on the medical perfusion technology market. In addition, complete analysis of changes on medical perfusion technology market expenditure, economic and international policies on supply and demand side. The report also studies the impact of pandemic on Asia Pacific economies, international trade, business investments, GDP and marketing strategies of key players present in the market. COVID-19 impact on the medical perfusion technology market is moderate owing to the decline in demand as many medical procedures are postponed in order to prevent the spread of COVID 19. However some of the companies are likely to involve in drug delivery in COVID 19. Such factors are likely to have an impact on medical perfusion technology market.
Asia pacific medical perfusion technology market has studied the segments by technique, organ type, component, and country.
Asia Pacific medical perfusion technology market is segmented into hypothermic machine perfusion and normothermic machine perfusion. The hypothermic machine perfusion segment is projected to witness high growth during the estimated timeframe whereas; normothermic machine perfusion is expected to dominate the market with highest CAGR from 2021 to 2027. As hypothermic perfusion machine has been developed to increase the storage time and reliability of the preservative process for the transplantable organ, this machine is in high demand. In addition this method includes continuous perfusion of the liver preservation solution which provides nutrients and can be also retain oxygen. This is ultimately boosting the growth of the segment.
By organ type medical perfusion market is segmented into heart, lungs, kidney, and liver. Kidney segment is dominating market. However heart segment is estimated to register highest CAGR in the market during forecast period. Rising cases of diabetes, obesity, high blood pressure or hypertension in turn increases heart failure cases in this country. This causes rise in demand of heart transplantation and ultimately increases the segment growth.
Based on components, medical perfusion technology market is segmented into perfusion pumps, oxygenators, heart-lung machines, monitoring system. Oxygenator is accounted for the largest share of the market by component. It is a medical device which is used to exchange oxygen and carbon dioxide in the blood of human patient during surgical procedures. Cardiopulmonary bypass procedure requires blood-gas exchanger that is oxygenator. Also, membrane oxygenators are used in long term support in treatment of acute respiratory failure, these applications of oxygenator propelling the growth of the segment.
Country wise, the study is comprised of the key countries such as the India china japan and rest of APAC. China held the largest share of Asia pacific market and is likely to dominate the medical perfusion technology market over the estimated time frame. Factors like increasing prevalence of cardiovascular diseases, growing geriatric population, funding provided by governments for research and development purpose and advancements in healthcare industry are likely to impel the growth of the market.
Major Key players of medical perfusion technology market are Getinge AB, Medtronic, LivaNova PLC, XVIVO Perfusion, Terumo Cardiovascular Systems Corporation, OrganOx Limited, Waters Medical Systems, TransMedics, Organ Recovery Systems, XENIOS AG, Paragonix Technologies, Shanghai Genext Medical Technology, Transplant Biomedicals SL and Dr. Franz Köhler Chemie GMBH among the others.
The study analysed several segments and their dominating or leading sub segments in the Asia Pacific medical perfusion market. Segments such as technique, organ type and country are covered in the study. Dominating technique segment is hypothermic perfusion technology; organ type segment is kidney; and component segment is oxygenator. Country wise, the study is comprised of the key countries such as the China, India, Japan and rest of APAC. China is dominating the market. The study also consists of impact of COVID 19 pandemic on the APAC medical perfusion technology market. It has hampered the growth of the market. As many surgical processes are postponed to stop the spread of COVID 19 Which shows negative impact on the market. Study also covers the major key players of medical perfusion technology.
April 2021: Livanova announced that it gains FDA clearance for its B-Capta system integrated into S5 heart –lung machine. The system is designed to monitoring arterial and venous blood gas parameters during long and complex by pass procedure. B-capta’s advanced sensing technology provides accurate measurements to perfusionist. The system includes accurate oxygen partial pressure a key measurement while performing goal directed perfusion
January 2019: Terumo launched its smallest, lowest prime volume, full size adult capiox oxygenator. It helps minimize the impact of cardiopulmonary bypass by reducing hemodilution, minimizing inflammatory response.
In May 2019, Terumo cardiovascular group and Talis clinical announced commercial release of AGC –perfusion and AGC- remote view system in North America. It enables Terumo to distribute Tali’s clinical ACG- perfusion and ACG-Remote View Systems in cardiac operating rooms and intensive care units.
Why to buy this report
The report offers changing market dynamics in the medical perfusion technology markets industry, presenting historical, current and projected market size in terms of value (USD Million)
The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of the medical perfusion technology market
It presents a comprehensive assessment of countries exhibiting promising growth, potential and niche segments and a neutral perspective of the medical perfusion technology market
The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of medical perfusion technology market